SCHEMBL16974909

SCHEMBL16974909

Fc1ccc2c(c1)SN=C(NCC(F)(F)F)N2

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16974836 0.85 IL1B (0.32) NOX1
SCHEMBL8584509 0.83 NOX1 (0.40) NOX1
SCHEMBL8582555 0.81 ADRA2A (0.38) NOX1
SCHEMBL8586554 0.80 NOX1 (0.37) NOX1
SCHEMBL8585872 0.79 NOX1 (0.44) NOX1
SCHEMBL8662194 0.78 ABL1 (0.38) NOX1
SCHEMBL8586573 0.78 NOX1 (0.36) NOX1
SCHEMBL8720094 0.78 L3MBTL1 (0.38)
SCHEMBL8582531 0.77 NOX1 (0.37) NOX1
SCHEMBL8580850 0.76 HTR2A (0.39) NOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099304-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA Mayo Foundation for Medical Education and Research (US) 2016-12-07 EP disclosed
WO-2015117024-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-08-06 WO disclosed